Trending
- Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemia
- Oxfordshire man climbs Kilimanjaro for school friend with cancer
- Inhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease
- Pyruvate carboxylase drives therapeutic resistance to KRAS G12C inhibitors in KEAP1-mutant lung cancer
- Supercentenarians’ superpower to suppress cancer
- Making Outpatient Cellular Therapy Dosing the Default in Multiple Myeloma
- Bruce Haffty, MD, and Mutlay Sayan, MD, on Radiation Oncology’s Next Frontier and Mentorship
- FDA OKs Pirtobrutinib in Frontline CLL/SLL
Saturday, October 3